VIVO
Weill Cornell Medical College
Index
Log in
Search form
Home
People
Organizations
Research
Support
Novel proteasome inhibitors targeting both beta5 and beta2 subunits for treatment of triple negative breast cancer
Grant
Overview
date/time interval
February 22, 2024 - December 31, 2028
awarded by
National Cancer Institute
administered by
Microbiology and Immunology
sponsor award ID
1 R01 CA276053-01A1
Affiliation
contributor
Lin, Gang
Principal Investigator
2024 - 2028
Ma, Xiaojing
Co-Investigator
2024 - 2028